Price as of close on Nov 3, 2026 · Financials updated Oct 6, 2026
Basics
Sector
Healthcare
Industry
Health Information Services
Country
United States
Market cap
13.8B USD
Enterprise value
13.7B USD
Full-time employees
23,500
Overall health
Drawback:higher risk than most peers: its share price swings more than most peers’ (beta 1.88 vs a peer median of 0.63), less short-term liquidity (current ratio 1.59 vs a peer median of 2.59) and more debt relative to equity (1.07× vs a peer median of 0.22×)higher risk: bigger price swings (beta 1.88 vs peers 0.63), less liquidity (current ratio 1.59 vs peers 2.59) and more debt vs equity (1.07× vs peers 0.22×)
About average: valuation
Ranks #523 of 1,157 healthcare companies (top 46%)
Stock pay outran buybacks. Stock-based pay expense $143M vs $44M spent repurchasing shares over the 3 fiscal years to 2025.
Over three fiscal years BrightSpring Health Services recorded $143M of stock-based pay expense and spent $44M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years BrightSpring Health Services recorded $143M of stock-based pay expense and spent $44M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.
Profit is backed by cash. Free cash flow is 110% of reported profit.
BrightSpring Health Services's free cash flow is 110% of its reported profit, so its earnings are turning into cash it can reinvest, pay out or use to reduce debt.
Fast revenue growth. Revenue grew 26% in the 12 months to June 2026 vs the 12 months before, faster than 84% of peers.
Revenue grew 26% in the 12 months to June 2026 vs the 12 months before, faster than 84% of its peers.
More volatile share price. Beta 1.88: tends to move more than the market.
BrightSpring Health Services's shares have swung more with the market than most peers' (beta 1.88, above the market's 1.0).
Valuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 56 → 53
Share price +19.7%-3
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
Earnings per share growth213.4%
SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 6.81Sector median: 0.0976 · MAD: 0.2991
3-year revenue growth18.7%
Yahoo Finance fallback · SEC figure unavailable or out of date · 3 fiscal years to Dec 2025Reported value33% base weight · Z-score 1.53Sector median: 0.0584 · MAD: 0.0840
Revenue growth26.4%
SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 2.08Sector median: 0.0609 · MAD: 0.0974
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about BrightSpring Health Services
Is BrightSpring Health Services getting weaker?
Its latest SEC filing (Jul 31, 2026) got weaker in some ways: share count up 2.0%. Its overall score is unchanged at 54/100 since Oct 28, 2026.
How is BrightSpring Health Services valued vs its peers?
Priced about in line with its peers. Valuation scores 53/100 against 1,393 healthcare peers.
Is BrightSpring Health Services growing?
Yes, faster than most of its peers. Growth scores 89/100 against 1,393 healthcare peers.Earnings per share growth 213.4% vs a peer median of 9.8% (stronger than 95% of peers).Earnings per share growth 213.4% vs peers 9.8% (stronger than 95% of peers).
How profitable is BrightSpring Health Services?
More profitable than most of its peers. Profitability scores 61/100 against 1,393 healthcare peers.Return on assets 6.1% vs a peer median of 1.7% (stronger than 77% of peers).Return on assets 6.1% vs peers 1.7% (stronger than 77% of peers).Operating margin 3.1% vs a peer median of 7.1% (weaker than 61% of peers).Operating margin 3.1% vs peers 7.1% (weaker than 61% of peers).
How risky is BrightSpring Health Services?
Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings.Beta 1.88 vs a peer median of 0.63 (weaker than 93% of peers).Beta 1.88 vs peers 0.63 (weaker than 93% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Jul 31, 2026 · compared with the quarter ended Mar 31, 2026
Got weaker
Share count up 2.0% (existing holders diluted)
Previous quarter
Latest quarter
Change
Revenue (12 months)
13.6B USD
14.4B USD
+5.3%
Net income (12 months)
308.3M USD
364.4M USD
+18.2%
Operating margin
2.7%
3.1%
+0.4 pts
Free cash flow (12 months)
412.1M USD
402.4M USD
−2.4%
Debt
2.5B USD
2.2B USD
−12.3%
Cash
888.8M USD
550.4M USD
−38.1%
Shares outstanding
193.9M
197.9M
+2.0%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Healthcare · 301 companies
Valuations in Healthcare are within their usual range since 2016.
52% of months since 2016 were valued lower than now.
19% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +8% and earnings +24% (medians): earnings grew faster than prices.
Median price-to-sales is +63% vs the whole market, against a usual +119%.
2016Shaded: most expensive fifth of its range2026
Shown for Healthcare: too few Health Information Services companies have a long enough history of their own.
Earnings-based measures are left out for now because many companies in Healthcare are losing money.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2022
FY 2023
FY 2024
FY 2025
Change
Gross margin
17.5%
14.8%
12.6%
11.8%
▼ 0.8 pts
Operating margin
2.4%
0.8%
1.1%
2.3%
▲ 1.2 pts
Net margin
-0.7%
-2.0%
-0.2%
1.5%
▲ 1.7 pts
Return on assets (ROA)
—
-2.8%
-0.3%
3.0%
▲ 3.3 pts
Return on equity (ROE)
-7.1%
-26.4%
-1.1%
10.2%
▲ 11 pts
Free cash flow margin
-1.0%
1.8%
-0.6%
3.1%
▲ 3.6 pts
Current ratio
—
1.17×
1.33×
1.57×
▲ 18%
Quick ratio
—
0.84×
0.88×
1.12×
▲ 28%
Debt to equity
—
5.75×
1.58×
1.34×
▼ 16%
Interest coverage
0.80×
0.21×
0.57×
1.88×
▲ 231%
BTSG price history
Price history is added with the daily price update and will appear after the next one.